NovoCure (NVCR) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, NovoCure (NVCR) reported revenue of $158.81 million, up 5.6% over the same period last year. EPS came in at -$0.36, compared to -$0.31 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $153.83 million, representing a surprise of +3.24%. The company delivered an EPS surprise of +7.69%, with the consensus EPS estimate being -$0.39.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...